Posted inCOVID-19 Vaccines
Moderna
Moderna, based in Cambridge, Massachusett., began it's inception in 2010 following Derek Rossi's breakthrough paper, demonstrating chemically modified mRNA could reprogram adult human fibroblast cells - the prelude to gene therapy. The main investor in the startup was Flagship Pioneering.…